Fitch Affirms McKesson’s L-T Ratings at ‘A-‘; Off Negative Watch

 | 1 Comment on Fitch Affirms McKesson’s L-T Ratings at ‘A-‘; Off Negative Watch

NEW YORK–(BUSINESS WIRE)–Fitch Ratings has affirmed the ratings of McKesson Corp. (McKesson) and removed them from Rating Watch Negative as follows upon the Dec. 30 close of the US Oncology, Inc. (US Oncology) transaction:

–Issuer Default Rating (IDR) at ‘A-‘;

–Short-term IDR at ‘F2’;

–Commercial Paper at ‘F2’;

–Senior Unsecured Bank Facility at ‘A-‘;

–Senior Unsecured Notes at ‘A-‘. Continue reading: Fitch Affirms McKesson’s L-T Ratings at ‘A-‘; Off Negative Watch

Mergers & Acquisitions Across EHR and HIT firms

 | No Comments on Mergers & Acquisitions Across EHR and HIT firms

With the herd of electronic medical record companies growing rapidly, we can expect to see things thin out over the next two years.  Once stage 1 and 2 Meaningful Use rules are finalized, be poised to start viewing a rapid genesis of companies joining forces and being acquired.  Smaller firms will have to join forces or seek increased venture capital in order to compete with the market share grasped by monoliths such as GE Healthcare, McKesson, NextGen (QSI), INGENIX (United Health Group) and now Allscripts. Continue reading: Mergers & Acquisitions Across EHR and HIT firms